Product Images Minivelle
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 17 images provide visual information about the product associated with Minivelle NDC 68968-6610 by Noven Therapeutics, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Minivelle is a transdermal system that contains 1.24 mg of estradiol USP, which delivers 0.075 mg/day. The system should be applied twice-weekly and contains an acrylic adhesive, silicone adhesive, and other inactive ingredients. It should be stored at 20°C to 25°C and should only be used transdermally. The package should be kept out of children's reach, and applied immediately after removing it from the pouch. Dosage and administration instructions can be found in the package insert. The manufacturer is Noven Pharmaceuticals, Inc. and the distributor is Noven Therapoutics, LLC, both located in Miami, Florida.*
This appears to be a product description for Minivelle, a transdermal system that delivers 0.1mg/day of estradiol USP. It comes in a package containing 8 systems and is applied twice-weekly. The product contains acrylic and silicone adhesive, oleyl alcohol, dipropylene glycol, among other inactive components. Package should be kept out of reach of children and stored at a controlled room temperature. The manufacturer is Noven Pharmaceuticals, Inc, and the distributor is Noven Therapoutics, LLC from Miami, Florida.*
The text describes statistical data of a study conducted over 12 weeks, with measurements taken at weeks 4, 8, and 12. The data includes numeric values for different variables and a comparison between a treatment called Vivelle and a placebo. The last sentence suggests that there was a statistically significant difference between the two treatments.*
This is a table or graph showing the % change from baseline for different treatments at different time points (Week 2, Week 26, Week 78, and Week 104). The treatments compared include Vivelle 0.1mg/day, Vivelle 0.025mg/day, Vivelle 0.05mg/day, Vivelle 0.0375mg/day, and Placebo.*
This text appears to be a table showing the percentage change from baseline for various treatments over the course of several weeks. The treatments are labeled A, B, C, D, and P. There are statistical values listed with some of the treatments, including p-values. The full extent of this data set is not available and any further interpretation of the data is not possible.*
This text is a list of three words "PIPPI", "Calendar", and "Pouch containing patch". It seems to describe a product or products, likely related to organization or storage.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.